-
Venture Valuation and Biotechgate to participate in the 2023 BIO International Convention in Boston
ZURICH, Switzerland, May 2023 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation […]
-
Interviews with leading Life Sciences companies: J-Pharma
J-Pharma is a frontrunner in developing inhibitors of L-type amino acid transporter for treating advanced […]
-
Venture Valuation/Biotechgate Partners with ALLIS-NA: Launch of Member Directory
Media Release Venture Valuation/Biotechgate Partners with ALLIS-NA: Launch of Member Directory Zurich, Switzerland and Paris, […]
-
Interviews with leading Life Sciences companies: Aipore
Aipore is developing AI-enabled solid-state nanospore sensor technology that can detect SARS-CoV2 coronavirus in saliva […]
-
Interviews with leading Life Sciences companies: Varinos Inc.
Varinos commercialized the world’s first highly accurate endometrial microbiome testing service by applying next-generation sequencing. […]
-
The World’s First Drug Discovery Platform Using Quantum Computing – POLARISqb
Founded in 2020 and winners of the XY Factor competition at Biotechgate Digital Partnering February […]
-
New treatment modality for amyloidosis related diseases – Vermilion Therapeutics
Developing a promising therapeutic technology which may contribute to treat various amyloidosis related diseases, incl. […]
-
Heartseed Inc., Breakthrough cell therapy for severe heart failure.
As an innovative new treatment option for heart failure, a unique cardiac remuscularization therapy has […]
-
How to assess start-up companies
Relevant soft factors to assess startup companies Investing in early-stage companies is a risky business. […]
-
Yone Production Co. Ltd., Succeeded, on the world’s first attempt
Established by KOBAYASHI Yonesaku, a well-known documentary cameraman and pioneer of cinephotomicrography, and Dr ASAKA […]